• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.

作者信息

Stoian Anca Pantea, Banerjee Yajnavalka, Rizvi Ali A, Rizzo Manfredi

机构信息

Diabetes, Nutrition and Metabolic Diseases, University of Bucharest, Bucharest, Romania.

Department of Biochemistry, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.

出版信息

Metab Syndr Relat Disord. 2020 May;18(4):173-175. doi: 10.1089/met.2020.0037. Epub 2020 Apr 9.

DOI:10.1089/met.2020.0037
PMID:32271125
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7196360/
Abstract
摘要

相似文献

1
Diabetes and the COVID-19 Pandemic: How Insights from Recent Experience Might Guide Future Management.糖尿病与新冠疫情：近期经验所得的见解如何指导未来管理
Metab Syndr Relat Disord. 2020 May;18(4):173-175. doi: 10.1089/met.2020.0037. Epub 2020 Apr 9.
2
Individualizing Inpatient Diabetes Management During the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间的住院糖尿病个体化管理
J Diabetes Sci Technol. 2020 Jul;14(4):705-707. doi: 10.1177/1932296820923045. Epub 2020 May 5.
3
Care for diabetes with COVID-19: Advice from China.2019冠状病毒病合并糖尿病的护理：来自中国的建议。
J Diabetes. 2020 May;12(5):417-419. doi: 10.1111/1753-0407.13036. Epub 2020 Apr 13.
4
Diabetes mellitus and COVID-19: A review and management guidance for South Africa.糖尿病与 COVID-19：南非的综述及管理指导。
S Afr Med J. 2020 Jun 18;110(8):761-766.
5
The Coronavirus 2019 Pandemic and Diabetes: An International Perspective.2019年冠状病毒大流行与糖尿病：国际视角
J Diabetes Sci Technol. 2020 Jul;14(4):703-704. doi: 10.1177/1932296820933075. Epub 2020 Jun 9.
6
Diabetes Management during the COVID-19 Pandemic: An Iranian Expert Opinion Statement.COVID-19 大流行期间的糖尿病管理：伊朗专家意见声明。
Arch Iran Med. 2020 Aug 1;23(8):564-567. doi: 10.34172/aim.2020.61.
7
Challenges of diabetes management during the COVID-19 pandemic.2019冠状病毒病大流行期间糖尿病管理面临的挑战。
Med J Aust. 2020 Jul;213(2):56-57.e1. doi: 10.5694/mja2.50665. Epub 2020 Jun 24.
8
Inpatient Diabetes and Hyperglycemia Management Protocol in the COVID-19 Era.新冠疫情时代住院患者糖尿病及高血糖管理方案
Am J Med Sci. 2020 Oct;360(4):423-426. doi: 10.1016/j.amjms.2020.07.005. Epub 2020 Jul 6.
9
COVID-19 and diabetes: No time to drag our feet during an untimely pandemic.2019冠状病毒病与糖尿病：在这场不合时宜的大流行期间，我们没时间拖沓了。
J Diabetes Complications. 2020 Sep;34(9):107621. doi: 10.1016/j.jdiacomp.2020.107621. Epub 2020 May 15.
10
How diabetes management is adapting amid the COVID-19 pandemic.在新冠疫情期间糖尿病管理是如何进行调整的。
Lancet Diabetes Endocrinol. 2020 Jul;8(7):571. doi: 10.1016/S2213-8587(20)30181-9. Epub 2020 May 15.

引用本文的文献

1
Effect of COVID-19 on hematological parameters and subsequent risk of anemia and bleeding in middle-aged and elderly patients with type 2 diabetes.2019冠状病毒病对中老年2型糖尿病患者血液学参数及后续贫血和出血风险的影响
J Family Med Prim Care. 2025 Jul;14(7):2974-2979. doi: 10.4103/jfmpc.jfmpc_5_25. Epub 2025 Jul 21.
2
Type 2 diabetes and susceptibility to COVID-19: a machine learning analysis.2 型糖尿病与 COVID-19 易感性：机器学习分析。
BMC Endocr Disord. 2024 Oct 21;24(1):221. doi: 10.1186/s12902-024-01758-3.
3
Substance P - a regulatory peptide with defense and repair functions. Results and perspectives for the fight against COVID-19.P物质——一种具有防御和修复功能的调节肽。抗击新冠疫情的成果与展望。
Front Neurol. 2024 May 30;15:1370454. doi: 10.3389/fneur.2024.1370454. eCollection 2024.
4
Potential Drugs in COVID-19 Management.新冠病毒管理中的潜在药物。
Curr Med Chem. 2024;31(22):3245-3264. doi: 10.2174/0929867331666230717154101.
5
Role of endothelial cells and angiotensin converting enzyme-II in COVID-19 and brain damages post-infection.内皮细胞和血管紧张素转换酶-II在COVID-19及感染后脑损伤中的作用。
Front Neurol. 2023 Jun 30;14:1210194. doi: 10.3389/fneur.2023.1210194. eCollection 2023.
6
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study.2019冠状病毒病的转归与糖尿病：一项多中心前瞻性队列综合研究
Microorganisms. 2023 May 27;11(6):1416. doi: 10.3390/microorganisms11061416.
7
Effect of COVID-19 on Glycemic Control, Insulin Resistance, and pH in Elderly Patients With Type 2 Diabetes.2019冠状病毒病对老年2型糖尿病患者血糖控制、胰岛素抵抗及pH值的影响
Cureus. 2023 Feb 23;15(2):e35390. doi: 10.7759/cureus.35390. eCollection 2023 Feb.
8
COVID-19: Diabetes Perspective-Pathophysiology and Management.2019冠状病毒病：糖尿病视角——病理生理学与管理
Pathogens. 2023 Jan 25;12(2):184. doi: 10.3390/pathogens12020184.
9
Associations between Periodontitis, COVID-19, and Cardiometabolic Complications: Molecular Mechanisms and Clinical Evidence.牙周炎、新冠病毒病与心血管代谢并发症之间的关联：分子机制与临床证据
Metabolites. 2022 Dec 26;13(1):40. doi: 10.3390/metabo13010040.
10
Absolute Hyperglycemia versus Stress Hyperglycemia Ratio for the Prognosis of Hospitalized Patients with COVID-19 in the First Months of the Pandemic: A Retrospective Study.大流行最初几个月中，绝对高血糖与应激性高血糖比值对COVID-19住院患者预后的影响：一项回顾性研究
Diabetes Ther. 2023 Feb;14(2):335-346. doi: 10.1007/s13300-022-01347-4. Epub 2022 Dec 27.

本文引用的文献

1
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
2
Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.在中国武汉，新冠肺炎糖尿病患者需要更好的血糖管理。
Metabolism. 2020 Jun;107:154216. doi: 10.1016/j.metabol.2020.154216. Epub 2020 Mar 24.
3
Telemedicine in the Era of COVID-19.新冠疫情时代的远程医疗
J Allergy Clin Immunol Pract. 2020 May;8(5):1489-1491. doi: 10.1016/j.jaip.2020.03.008. Epub 2020 Mar 24.
4
COVID-19 and Italy: what next?COVID-19 和意大利：下一步如何？
Lancet. 2020 Apr 11;395(10231):1225-1228. doi: 10.1016/S0140-6736(20)30627-9. Epub 2020 Mar 13.
5
Clinical considerations for patients with diabetes in times of COVID-19 epidemic.2019冠状病毒病疫情期间糖尿病患者的临床考量
Diabetes Metab Syndr. 2020 May-Jun;14(3):211-212. doi: 10.1016/j.dsx.2020.03.002. Epub 2020 Mar 10.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Patients' and caregivers' experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study.患者及护理人员使用持续血糖监测支持糖尿病自我管理的体验：定性研究
BMC Endocr Disord. 2018 Feb 20;18(1):12. doi: 10.1186/s12902-018-0239-1.
8
Patients' Satisfaction with and Preference for Telehealth Visits.患者对远程医疗就诊的满意度及偏好
J Gen Intern Med. 2016 Mar;31(3):269-75. doi: 10.1007/s11606-015-3489-x. Epub 2015 Aug 13.
9
Utilizing patient portal functionality within an EMR system.利用电子病历系统中的患者门户功能。
J Med Pract Manage. 2012 Nov-Dec;28(3):183-6.
10
Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS.血糖水平和糖尿病是严重急性呼吸综合征（SARS）患者死亡率和发病率的独立预测因素。
Diabet Med. 2006 Jun;23(6):623-8. doi: 10.1111/j.1464-5491.2006.01861.x.